Term: ribonucleotide reductase inhibitor Pronunciation: (RY-boh-NOO-klee-oh-tide ree-DUK-tays in-HIH-bih-ter) May 24, 2024October 7, 2025 Description: A family of anticancer drugs that interfere with the growth of tumor cells by blocking the formation of deoxyribonucleotides (building blocks of DNA). Related Posts:Pacritinib for Myelofibrosis - A New JAK-2 Inhibitor…FDA Approves ALIQOPA®, a PI3K Inhibitor, for…FDA Approves ALIQOPA®, a PI3K Inhibitor, for…FDA Approves First PI3K Inhibitor, PIQRAY®, for…LAG-3 Inhibitor Relatlimab and OPVIDO® in Advanced…FDA Approves BCL2 Inhibitor VENCLEXTA® for Chronic…